Cyber attack hits Merck results, Keytruda notches new milestone

Merck & Co. on Friday said quarterly sales of its Keytruda cancer immunotherapy exceeded $1 billion for the first time, but the cost of a cyber attack that temporarily crippled manufacturing and declines in off-patent products caused overall revenue to fall.

from Business Insurance http://ift.tt/2xtrjZ6